Here are six notes:
1. AmSurg presently has a price target of $95.00.
2. AmSurg surpassed Zacks’ consensus estimate because of the company’s focus on organic growth and acquisition strategies.
3. AmSurg stock opened at $82.44 on Thursday, Aug. 6.
4. The company has a market cap of $3.93 billon and a P/E ration of 71.19.
5. AmSurg’s 50-day moving average price is $71.54 and its 200-day moving price is $64.80.
6. The company has a one-year low of $47.68 and a one-year high of $85.52.
More on surgery centers:
Barclay analysts raise SCA price target to $45 — 5 notes
Revere Health to break ground on new facility, surgery center
28 ASC joint ventures & acquisitions in 2015 so far
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
